Search Results - "Falvella, Felicia S."

Transcription Deregulation at the 15q25 Locus in Association with Lung Adenocarcinoma Risk by FALVELLA, Felicia S, GALVAN, Antonella, FRULLANTI, Elisa, SPINOLA, Monica, CALABRO, Elisa, CARBONE, Antonino, INCARBONE, Matteo, SANTAMBROGIO, Luigi, PASTORINO, Ugo, DRAGANI, Tommasoa

“…Purpose: We characterized the candidacy of the six candidate genes mapping in the chromosome 15q25 locus, which was previously reported as associated with lung…”
Get full text

Multiple Loci Modulate Opioid Therapy Response for Cancer Pain by GALVAN, Antonella, SKORPEN, Frank, DRAGANI, Tommaso A, KLEPSTAD, Pål, KNUDSEN, Anne Kari, FLADVAD, Torill, FALVELLA, Felicia S, PIGNI, Alessandra, BRUNELLI, Cinzia, CARACENI, Augusto, KAASA, Stein

“…Patients treated with opioid drugs for cancer pain experience different relief responses, raising the possibility that genetic factors play a role in opioid…”
Get full text

A Comprehensive Appraisal of Laboratory Biochemistry Tests as Major Predictors of COVID-19 Severity by Aloisio, Elena, Chibireva, Mariia, Serafini, Ludovica, Pasqualetti, Sara, Falvella, Felicia S, Dolci, Alberto, Panteghini, Mauro

“…A relevant portion of coronavirus disease 2019 (COVID-19) patients develop severe disease with negative outcomes. Several biomarkers have been proposed to…”
Get full text

MFSD2A is a novel lung tumor suppressor gene modulating cell cycle and matrix attachment by Spinola, Monica, Falvella, Felicia S, Colombo, Francesca, Sullivan, James P, Shames, David S, Girard, Luc, Spessotto, Paola, Minna, John D, Dragani, Tommaso A

“…MFSD2A (major facilitator superfamily domain containing 2) gene maps on chromosome 1p34 within a linkage disequilibrium block containing genetic elements…”
Get full text

A 5'-region polymorphism modulates promoter activity of the tumor suppressor gene MFSD2A by Colombo, Francesca, Falvella, Felicia S, Galvan, Antonella, Frullanti, Elisa, Kunitoh, Hideo, Ushijima, Toshikazu, Dragani, Tommaso A

“…The MFSD2A gene maps within a linkage disequilibrium block containing the MYCL1-EcoRI polymorphism associated with prognosis and survival in lung cancer…”
Get full text

HLA-B57 by Falvella, Felicia S, Cheli, Stefania, Clementi, Emilio

Get full text

Association of lung adenocarcinoma clinical stage with gene expression pattern in noninvolved lung tissue by Frullanti, Elisa, Colombo, Francesca, Falvella, Felicia S., Galvan, Antonella, Noci, Sara, De Cecco, Loris, Incarbone, Matteo, Alloisio, Marco, Santambrogio, Luigi, Nosotti, Mario, Tosi, Davide, Pastorino, Ugo, Dragani, Tommaso A.

“…Associations between clinical outcome of cancer patients and the gene expression signature in primary tumors at time of diagnosis have been reported. To test…”
Get full text

Eltrombopag-Induced Acute Liver Failure in a Pediatric Patient: A Pharmacokinetic and Pharmacogenetic Analysis by Marano, Marco, Serafinelli, Jessica, Cairoli, Sara, Martinelli, Diego, Pisani, Mara, Palumbo, Giuseppe, Cefalo, Maria G, Cecchetti, Corrado, Di Nardo, Matteo, Falvella, Felicia S, Goffredo, Bianca M

“…Eltrombopag is an oral thrombopoietin receptor agonist approved for the treatment of patients with chronic idiopathic thrombocytopenic purpura (ITP), who are…”
Get full text

Pharmacokinetics and Pharmacogenetics of Selective Serotonin Reuptake Inhibitors During Pregnancy: An Observational Study by Pogliani, Laura, Falvella, Felicia S, Cattaneo, Dario, Pileri, Paola, Moscatiello, Anna F, Cheli, Stefania, Baldelli, Sara, Fabiano, Valentina, Cetin, Irene, Clementi, Emilio, Zuccotti, Gianvincenzo

“…An involvement of selective serotonin reuptake inhibitors (SSRIs) in increasing the risk of malformations, neonatal withdrawal syndrome, has been suggested…”
Get full text

Promoter Polymorphisms and Transcript Levels of Nicotinic Receptor CHRNA5 by Falvella, Felicia S., Galvan, Antonella, Colombo, Francesca, Frullanti, Elisa, Pastorino, Ugo, Dragani, Tommaso A.

“…Chromosomal locus 15q25, implicated in lung cancer risk and nicotine dependence, shows extensive linkage disequilibrium that complicates identification of…”
Get full text

Multiple isoforms and differential allelic expression of CHRNA5 in lung tissue and lung adenocarcinoma by Falvella, Felicia S, Alberio, Tiziana, Noci, Sara, Santambrogio, Luigi, Nosotti, Mario, Incarbone, Matteo, Pastorino, Ugo, Fasano, Mauro, Dragani, Tommaso A

“…CHRNA5 gene expression variation may play a role in individual susceptibility to lung cancer. Analysis of CHRNA5 transcripts expressed in normal lung tissue…”
Get full text

The combination of pharmacogenetic and pharmacokinetic analyses to optimize clomipramine dosing in major depression: a case report by Antoniazzi, Stefania, Tatulli, Alessandro, Falvella, Felicia S., Cigliobianco, Michela, Paoli, Riccardo A., Cattaneo, Dario, Cheli, Stefania, Bernardi, Francesca F., Clementi, Emilio, Altamura, Carlo A.

“…Summary What is known and objective Polymorphisms in cytochrome P450 2D6 and 2C19 can lead to interindividual differences in drug plasma concentrations,…”
Get full text

LightSNiP assay is a good strategy for pharmacogenetics test by Cheli, Stefania, Pietrantonio, Filippo, Clementi, Emilio, Falvella, Felicia S

Get full text

FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung by Falvella, Felicia S., Frullanti, Elisa, Galvan, Antonella, Spinola, Monica, Noci, Sara, De Cecco, Loris, Nosotti, Mario, Santambrogio, Luigi, Incarbone, Matteo, Alloisio, Marco, Calabrò, Elisa, Pastorino, Ugo, Skaug, Vidar, Haugen, Aage, Taioli, Emanuela, Dragani, Tommaso A.

“…The association of the fibroblast growth factor receptor 4 (FGFR4) Gly388Arg polymorphism with clinical stage and overall survival in a series of 541 Italian…”
Get full text

Multiple Genetic Loci Modulate Lung Adenocarcinoma Clinical Staging by FRULLANTI, Elisa, GALVAN, Antonella, GONZALEZ-NEIRA, Anna, PASTORINO, Ugo, DRAGANI, Tommaso A, FALVELLA, Felicia S, MANENTI, Giacomo, COLOMBO, Francesca, VANNELLI, Alberto, INCARBONE, Matteo, ALLOISIO, Marco, NOSOTTI, Mario, SANTAMBROGIO, Luigi

“…The main prognostic factor of lung cancer patient outcome is clinical stage, a parameter of tumor aggressiveness. Our study was conducted to test whether germ…”
Get full text

Genome-wide association study in discordant sibships identifies multiple inherited susceptibility alleles linked to lung cancer by Galvan, Antonella, Falvella, Felicia S., Frullanti, Elisa, Spinola, Monica, Incarbone, Matteo, Nosotti, Mario, Santambrogio, Luigi, Conti, Barbara, Pastorino, Ugo, Gonzalez-Neira, Anna, Dragani, Tommaso A.

“…We analyzed a series of young (median age = 52 years) non-smoker lung cancer patients and their unaffected siblings as controls, using a genome-wide 620 901…”
Get full text

A polygenic model with common variants may predict lung adenocarcinoma risk in humans by Galvan, Antonella, Falvella, Felicia S., Spinola, Monica, Frullanti, Elisa, Leoni, Vera P., Noci, Sara, Alonso, Maria R., Zolin, Anna, Spada, Elena, Milani, Silvano, Pastorino, Ugo, Incarbone, Matteo, Santambrogio, Luigi, Neira, Anna Gonzalez, Dragani, Tommaso A.

“…Genome‐wide screening for genetic loci associated with risk of lung adenocarcinoma (ADCA) was carried out in pooled DNA using the Illumina 300K…”
Get full text

Reply to the Letter to the Editor from Wang by Falvella, Felicia S., Galvan, Antonella, Frullanti, Elisa, Dragani, Tommaso A.

Get full text

MFSD2A is a novel lung tumour suppressor gene whose expression is modulated by a 5’-region polymorphism by Colombo, Francesca, Spinola, Monica, Falvella, Felicia S, Sullivan, James P, Shames, David S, Girard, Luc, Spessotto, Paola, Minna, John D, Dragani, Tommaso A

Get full text

The combination of pharmacogenetic and pharmacokinetic analyses to optimize clomipramine dosing in major depression: a case report by Antoniazzi, Stefania, Tatulli, Alessandro, Falvella, Felicia S, Cigliobianco, Michela, Paoli, Riccardo A, Cattaneo, Dario, Cheli, Stefania, Bernardi, Francesca F, Clementi, Emilio, Altamura, Carlo A

“…WHAT IS KNOWN AND OBJECTIVEPolymorphisms in cytochrome P450 2D6 and 2C19 can lead to interindividual differences in drug plasma concentrations, affecting…”
Get full text